Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Atlas South Sea Pearl Limited
Atlas South Sea Pearl To Deregister From SEC and Terminate its U.S. Reporting Obligations
July 6th, 2008
Atlas South Sea Pearl Limited ("Atlas") announced that it intends to file a Form 15F with the U.S. Securities and Exchange Commission ("SEC") on June 30, 2008 to terminate the registration of its ordinary shares in the form of American Depositary Shares evidenced by American Depositary Receipts ("ADR's") thereby immediately suspending its obligation to file annual and other reports with the SEC pursuant to the U.S. Securities Exchange Act of 1934. Atlas expects this termination of registration to become effective 90 days after the filing of the Form 15F. Atlas filed a Form 25 on July 11, 2007 terminating the listing of its "level two" ADR's on the NASDAQ Capital Market...
Source: Pharma Investments, Ventures & Law Weekly (2008-07-06)
|
